MedPath

Baxter Deutschland GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:2

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Ifosfamide for Injection

Product Name
和乐生
Approval Number
国药准字HJ20140099
Approval Date
Oct 30, 2023
NMPA

Cyclophosphamide for Injection

Product Name
安道生
Approval Number
国药准字HJ20160468
Approval Date
Jun 8, 2021
NMPA

Cyclophosphamide for Injection

Product Name
安道生
Approval Number
国药准字HJ20160467
Approval Date
Jun 8, 2021
NMPA

Mesna Injection

Product Name
UROMITEXAN
Approval Number
国药准字HJ20160239
Approval Date
Feb 27, 2021
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath